Have compounding pharmacies such as New England Compounding Company, which is the cause of the nation-wide meningitis outbreak, evaded better regulatory oversight through campaign donations to Congress? The New York Times thinks so: Friends In Congress Have Helped Drug Compounders Evade Tighter Rules.
I don't know the answer to the question, but I heard once that "money doesn't talk, it swears."
